Rocket Pharmaceuticals (RCKT) Revenue & Revenue Breakdown
Rocket Pharmaceuticals Revenue Highlights
Rocket Pharmaceuticals Revenue by Period
Rocket Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | 100.00% |
| 2012-12-31 | - | - |
Rocket Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Rocket Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $10.31M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | 100.00% |
| 2013-12-31 | - | - |
Rocket Pharmaceuticals generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Rocket Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MIRM | Mirum Pharmaceuticals | $186.37M | $69.22M |
| STRO | Sutro Biopharma | $153.73M | $13.01M |
| RGNX | REGENXBIO | $90.24M | $22.30M |
| RYTM | Rhythm Pharmaceuticals | $77.43M | $25.97M |
| MRUS | Merus | $43.95M | $7.33M |
| QURE | uniQure | $15.84M | $11.13M |
| MGTX | MeiraGTx | $14.02M | $282.00K |
| RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| CYTK | Cytokinetics | $7.53M | $249.00K |
| PLRX | Pliant Therapeutics | $1.58M | - |
| VRDN | Viridian Therapeutics | $314.00K | $72.00K |
| PCVX | Vaxcyte | - | - |
| DAWN | Day One Biopharmaceuticals | - | $8.19M |
| INZY | Inozyme Pharma | - | - |
| DYN | Dyne Therapeutics | - | - |
| REPL | Replimune Group | - | - |
| RCKT | Rocket Pharmaceuticals | - | - |
| SNDX | Syndax Pharmaceuticals | - | $3.50M |
| LRMR | Larimar Therapeutics | - | - |
| SLDB | Solid Biosciences | - | - |
RCKT Revenue FAQ
What is Rocket Pharmaceuticals’s yearly revenue?
Rocket Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. RCKT's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Rocket Pharmaceuticals’s quarterly revenue?
Rocket Pharmaceuticals's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). RCKT's quarterly revenue for Q4 2023 was $10.31M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Rocket Pharmaceuticals’s revenue growth rate?
Rocket Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.